SecBot SecBot
144 ·Filed Aug 17, 2026

NMRA

Neumora Therapeutics, Inc.
BEARISH
Impact 5/10
Horizondays Processed3mo ago SEC0001964306-26-000398
Form 144, notice of proposed sale of securities
Actionable Insight ▼ Bearish

The Form 144 filing by an officer signals potential insider selling. Given the small relative size (0.07% of market cap), the direct impact is limited, but it may indicate insider sentiment. Monitor for actual Form 4 filings to confirm the sale and watch for any subsequent insider selling patterns.

DirectionBearish
Confidencemedium
Horizondays

How the stock moved after the report

BEARISH VIEWSTOCK BELOW ENTRY AT T+60
Entry
$1.64
T+0 close · Aug 17, 2026 · via day close
Latest settled
−71.16%
T+60 · $0.4730
Vs SPY
−70.16%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Aug 18 $1.64entry
  2. T+1 · 3mo ago 0.00%α −0.21% · $1.64
  3. T+5 · 3mo ago −8.54%α −8.34% · $1.50
  4. T+20 · 2mo ago −52.85%α −51.54% · $0.7732
  5. T+60 · 6d ago −71.16%α −70.16% · $0.4730
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Aurora Daljit Singh, an officer of Neumora Therapeutics, filed a Form 144 notice of intent to sell 146,706 shares of common stock, with an approximate market value of $220,135. The shares were acquired through the exercise of employee stock options and vesting of restricted stock units. This filing signals the insider's intent to sell, though the sale may not be executed.

Key Facts

  • Officer Aurora Daljit Singh filed Form 144 to sell 146,706 shares.
  • Estimated market value of the proposed sale is $220,135.
  • Shares were acquired through exercise of employee stock options and vesting of RSUs.
  • The filing date is August 17, 2026.
  • The company has a market cap of $296M.

Financial Impact

Proposed sale of 146,706 shares valued at approximately $220,135, representing about 0.07% of the company's $296M market cap.

dilutioninsider ownership

Risk Factors

  • Insider selling could signal lack of confidence in near-term prospects.
  • The sale may not be executed; Form 144 is only an intent to sell.
  • Biotech sector volatility could amplify any negative sentiment from insider selling.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
80% bullish (15 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001964306-26-000398
Document: 0001964306-26-000398-index.html0001964306-26-000398
Document: 0001964306-26-000398.txt0001964306-26-000398

Track record

14 reports on NMRA

Performance horizon

2 of 5 bullish or bearish reports moved the stock their way by T+5. Best: +77.33% at T+60 after the Aug 20, 2026 report. 4 of 5 went positive at some point.

Filters
  1. Nov 16, 2026today SC 13G/A Neutral 2/10 Entry $0.3760 Now $0.3700 −1.60% settles Nov 24
  2. Nov 16, 2026today Press Release Neutral 4/10 Entry $0.4206 Now $0.3700 −12.03% settles Nov 23
  3. Oct 30, 202617d ago 8-K Bearish 7/10 Entry $0.4957 to $0.4859 Now $0.3700 +25.36% ▲ +1.98% +2.06% vs SPY
  4. Sep 22, 20267w ago Institutional Cluster Neutral 3/10 Entry $0.7785 to $0.6776 Now $0.3700 −52.47% ▼ −12.96% −11.77% vs SPY
  5. Aug 20, 202612w ago 144 Bearish 5/10 Entry $1.63 to $1.39 Now $0.3700 +77.30% ▲ +14.72% +15.20% vs SPY
  6. Aug 17, 202613w ago 144 Bearish 5/10 Viewing Entry $1.64 to $1.50 Now $0.3700 +77.44% ▲ +8.54% +8.34% vs SPY
  7. Aug 14, 202613w ago 8-K Neutral 4/10 No price data
  8. Aug 14, 202613w ago Press Release Neutral 4/10 Entry $1.60 to $1.63 Now $0.3700 −76.87% ▲ +1.88% +3.24% vs SPY
  9. Jul 27, 202616w ago 8-K Bullish 5/10 Entry $1.66 to $1.61 Now $0.3700 −77.71% ▼ −3.01% −4.09% vs SPY
  10. Jul 27, 202616w ago Press Release Bullish 7/10 Entry $1.66 to $1.61 Now $0.3700 −77.71% ▼ −3.01% −4.09% vs SPY
Showing 10 of 14

US Market Status

Market Closed · Opens in 6h 38m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Aug 17, 2026